Enhanced Prediction Model for Major Adverse Events Following Acute Myocardial Infarction

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University

About this trial

Acute myocardial infarction (AMI) remains a leading cause of mortality worldwide. Although early revascularization has markedly improved short-term outcomes, the incidence of major adverse cardiovascular events after the index event remains unacceptably high, posing a formidable clinical challenge. Contemporary risk-stratification instruments rely predominantly on a restricted set of conventional clinical variables and therefore fail to capture the full spectrum of individual pathophysiological complexity. To overcome these limitations, the present investigation aims to develop a post-AMI prognostic model that integrates comprehensive multimodal data.

Eligibility criteria

Qualifiers

Age ≥18 years old

Presented with myocardial infarction, including NSTEMI and STEMI

Undergoing successful percutaneous coronary intervention.

Disqualifiers

Subjects who decline protocol-mandated follow-up or withhold informed consent.

Individuals whose expected survival is < 1 year.

Trial design

Treatments tested in this trial

  • Percutaneous coronary intervention

Treatment groups

1,544 Participants
are divided into 1 treatment group